Lyssikatos Joseph P Insider Trading Activity
Lyssikatos Joseph P has been net-selling over the last 12 months with 0 purchases and 17 sales across 1 company.
ELVN is the most-traded position with 17 trades. The largest single transaction was a sale of ELVN for $1.5M on Jan 9, 2026.
Performance Scorecard
Forward stock performance after each transaction by Lyssikatos Joseph P. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.0% | 38% | 21 |
| 90 days | — | -28.5% | 33% | 21 |
| 120 days | — | -36.5% | 19% | 21 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersELVN · Enliven Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Lyssikatos Joseph P bought and sold ELVN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Feb 6, 2026 | ELVN | Sell | 5,000 | $29.04 | $145K | −0.7% | CHIEF SCIENTIFIC OFFICER | |
Jan 20, 2026 | ELVN | Sell | 5,491 | $26.37 | $145K | −0.7% | CHIEF SCIENTIFIC OFFICER | |
Jan 20, 2026 | ELVN | Sell | 14,509 | $26.90 | $390K | −1.9% | CHIEF SCIENTIFIC OFFICER | |
Jan 9, 2026 | ELVN | Sell | 41,198 | $24.90 | $1.0M | −4.8% | CHIEF SCIENTIFIC OFFICER | |
Jan 9, 2026 | ELVN | Sell | 50,000 | $29.13 | $1.5M | −6.1% | CHIEF SCIENTIFIC OFFICER | |
Jan 8, 2026 | ELVN | Sell | 7,500 | $20.13 | $151K | −0.8% | CHIEF SCIENTIFIC OFFICER | |
Jan 8, 2026 | ELVN | Sell | 33,802 | $24.92 | $842K | −3.8% | CHIEF SCIENTIFIC OFFICER | |
Dec 19, 2025 | ELVN | Sell | 5,000 | $16.84 | $84K | −0.6% | CHIEF SCIENTIFIC OFFICER | |
Nov 19, 2025 | ELVN | Sell | 492 | $23.09 | $11K | −0.1% | CHIEF SCIENTIFIC OFFICER | |
Nov 19, 2025 | ELVN | Sell | 12,008 | $22.30 | $268K | −1.3% | CHIEF SCIENTIFIC OFFICER | |
Oct 20, 2025 | ELVN | Sell | 12,500 | $22.08 | $276K | −1.3% | CHIEF SCIENTIFIC OFFICER | |
Sep 26, 2025 | ELVN | Sell | 4,000 | $20.25 | $81K | −0.4% | CHIEF SCIENTIFIC OFFICER | |
Sep 23, 2025 | ELVN | Sell | 1,500 | $20.03 | $30K | −0.2% | CHIEF SCIENTIFIC OFFICER | |
Sep 19, 2025 | ELVN | Sell | 4,870 | $19.11 | $93K | −0.5% | CHIEF SCIENTIFIC OFFICER | |
Sep 19, 2025 | ELVN | Sell | 2,130 | $20.02 | $43K | −0.2% | CHIEF SCIENTIFIC OFFICER | |
Aug 21, 2025 | ELVN | Sell | 7,500 | $20.01 | $150K | −0.8% | CHIEF SCIENTIFIC OFFICER | |
Aug 19, 2025 | ELVN | Sell | 5,000 | $19.62 | $98K | −0.5% | CHIEF SCIENTIFIC OFFICER | |
Jul 21, 2025 | ELVN | Sell | 11,924 | $22.26 | $265K | −1.2% | CHIEF SCIENTIFIC OFFICER | |
Jul 21, 2025 | ELVN | Sell | 576 | $22.90 | $13K | −0.1% | CHIEF SCIENTIFIC OFFICER | |
Jun 20, 2025 | ELVN | Sell | 12,500 | $21.40 | $267K | −1.3% | CHIEF SCIENTIFIC OFFICER | |
Jun 3, 2025 | ELVN | Sell | 7,500 | $20.03 | $150K | −0.8% | CHIEF SCIENTIFIC OFFICER |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 21 | $6.0M |
Other insiders at Enliven Therapeutics, Inc.
5 other tracked filers at ELVN.